Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
“Giorgio Prodi” Cancer Research Center, |
RCV001799813 | SCV002026130 | pathogenic | Gastrointestinal stromal tumor | 2021-10-01 | criteria provided, single submitter | research | |
Ambry Genetics | RCV002343850 | SCV002646496 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-11-02 | criteria provided, single submitter | clinical testing | The p.Q176* pathogenic mutation (also known as c.526C>T), located in coding exon 5 of the SDHA gene, results from a C to T substitution at nucleotide position 526. This changes the amino acid from a glutamine to a stop codon within coding exon 5. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |